Novel uses
AssigneeNanyang Polytechnic
InventorsMark Richards, Chee Wee Phoon, Mun Kin Lee
Life of this patent
Estimating the term…
Loading patent…
AssigneeNanyang Polytechnic
InventorsMark Richards, Chee Wee Phoon, Mun Kin Lee
Estimating the term…
The present invention relates to the use of a compound represented by the general formula (I), and pharmaceutically acceptable salts thereof, wherein: n is an integer from 2 to 5; p is an integer from 0 to 4; R1 is selected from the group consisting of a hydroxyl group, an alkoxy group, a thiol group, a thioether group, and an amino group, wherein at least two of R1 is a hydroxyl group, a thiol group or an amino group, with the proviso that wherein n is 2, R1 is not on the carbon-2 position and the carbon-5 position of the phenyl group; R2 and R3 are independently a methylene group or a nucleophile, with the proviso that at least one of R2 and R3 is a nucleophile group; Z is an oxygen (O) atom or sulfur (S) atom; T is hydrogen or an optionally substituted aliphatic group; in the manufacture of a medicament for treating a patient in need of cell therapy.
1-92. (canceled)
A method for removing undifferentiated stem cells or dedifferentiated stem cells from a sample comprising said cells, the method comprising administering to said cell sample an effective amount of a compound of the formula (I):
A method for the treatment of a patient in need of cell therapy, the method comprising administering to the patient an effective amount of a compound represented by the general formula (I):
Dependencies are inferred from the claim text.